n-benzyladriamycin-14-valerate and Bone Neoplasms

n-benzyladriamycin-14-valerate has been researched along with Bone Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cekanova, M; Rathore, K	1

Other Studies

1 other study(ies) available for n-benzyladriamycin-14-valerate and Bone Neoplasms

Article	Year
A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitro. Drug design, development and therapy, 2015, Volume: 9 Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Apoptosis Regulatory Proteins; Bone Neoplasms; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Proliferation; Cell Shape; Cell Survival; Dogs; Dose-Response Relationship, Drug; Doxorubicin; Osteosarcoma; p38 Mitogen-Activated Protein Kinases; Protein Kinase C-delta; Signal Transduction	2015

Article

Year

A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitro.

Drug design, development and therapy, 2015, Volume: 9

Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Apoptosis Regulatory Proteins; Bone Neoplasms; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Proliferation; Cell Shape; Cell Survival; Dogs; Dose-Response Relationship, Drug; Doxorubicin; Osteosarcoma; p38 Mitogen-Activated Protein Kinases; Protein Kinase C-delta; Signal Transduction

2015